Heart Disease Trial, Recruiting NCT06070662 Sponsor: University of Leicester Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06070662
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are already taking part in the 'CMR versus CT-FFR in CAD' study
  • People aged 18 or older
  • People who have been referred for an invasive coronary angiography (a procedure to look at the heart's arteries) to investigate chest pain
  • People who are willing and able to give their consent to participate
  • People who are willing and able to follow all the study requirements, in the opinion of the researchers
  • People who agree to allow their GP and relevant specialist to be told about their participation
  • People who can read and understand written English
  • People who are able to exercise while inside an MRI scanner
  • Study arm: People whose CT scan (a special heart imaging test done as part of the research) showed no blockages or narrowing in the heart arteries, but whose MRI stress test showed a problem with blood flow to the heart muscle that suggests a condition called coronary microvascular dysfunction (CMD)
  • Control arm: People whose CT scan (done as part of the research) showed narrowing or blockages in more than one heart artery

Who may not be able to join:

  • People who have had a heart attack or serious heart event in the past 6 months
  • People with severe claustrophobia (extreme fear of enclosed spaces)
  • People with certain devices or implants that are not safe or compatible with MRI scanning (note: people with devices that are MRI-conditional or MRI-safe may still be included — confirm with trial site)
  • People with a specific type of irregular heart rhythm called second- or third-degree atrioventricular block
  • People with severe chronic obstructive pulmonary disease (a serious long-term lung condition)
  • People with moderate to severe asthma
  • People whose kidneys are not working well enough (based on a specific blood test result below a certain level)
  • Women who are pregnant, breastfeeding, or who could become pregnant (premenopausal women)
  • People who have a known reaction or allergy to the contrast dye used in CT scans
  • People who have taken part in a research study involving an experimental treatment in the past 12 weeks
  • People who cannot read or understand written English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ranjit Arnold, University of Leicester

Phone: +44116 258 3038

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Leicester
Registry
ClinicalTrials.gov
Start date
1 November 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

The ability of coronary luminal volume to myocardial mass (V/M) ratio measured using CT to identify the presence of CMD demonstrated by invasive coronary physiological assessment in patients with angina.; The ability of T1 mapping at rest and exercise to identify the presence of CMD demonstrated by invasive coronary physiological assessment in patients with angina.; The ability of Blood oxygen level-dependent CMR (BOLD-CMR) at rest and exercise at rest and exercise to identify the presence of CMD demonstrated by invasive coronary physiological assessment in patients with angina.; The ability o...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov